The appropriate amount of protein to use in infant formula is still under discussion. We found earlier that protein digestibility is higher from ultrahigh-temperature (UHT)-treated formula than from conventionally heat-treated formula. In this study, we evaluated the nutritional, hematologic, and biochemical effects of feeding infants whey-predominant UHT-treated formula with 13 (UHT-13) or 15 (UHT-15) g protein/L as compared with a conventional, powdered, whey-predominant formula (PF) with 13 g protein/L from 6 wk to 6 mo of age. Breast-fed infants served as control subjects. Growth was assessed at monthly intervals and venous blood samples were drawn at entry into the study and at 6 mo of age. At 6 mo, there were no significant differences in weight gain or linear growth, or hemoglobin, serum ferritin, zinc, or copper concentrations among the groups. Blood urea nitrogen concentrations were lowest for breast-fed infants; among the formula-fed groups the UHT-13 group had the lowest values. All formula-fed groups had higher plasma threonine concentrations than breast-fed infants. Infants fed the UHT-13 formula had threonine values closest to those of breast-fed infants. Concentrations of branched-chain amino acids were similar in breast-fed infants and those fed UHT-13 formula, whereas the other groups had higher values. Plasma tryptophan concentrations were significantly higher in the UHT-treated formula groups than in the other groups. Thus, infants fed UHT-13 formula had metabolic measures similar to those of breast-fed infants, possibly because of high protein digestibility, or a difference in the protein source used. Iron, zinc, and copper status was satisfactory in all groups. Selenium status, as indicated by serum glutathione peroxidase activity, varied with dietary selenium intake.
INTRODUCTION
The protein concentration of mature breast milk is only Ϸ8-9 g/L, whereas it is Ϸ10-13 g/L in early lactation (1) (2) (3) . To compensate for perceived lower digestibility of cow milk protein and to achieve an adequate supply of all amino acids, most infant formulas to date have had a protein concentration of 15-16 g/L or higher. However, several studies have shown that plasma amino acid patterns and blood urea nitrogen (BUN) concentrations in infants fed whey-predominant milk formula with Ϸ13 g protein/L are very similar to those of breast-fed infants (4) (5) (6) (7) . Powdered formulas were used in all of these studies.
During processing, infant formulas are heat treated to maintain the bacteriologic quality of the product. Traditionally, this has been either retort sterilization for liquid products or hightemperature, short-time (HTST) treatment before spray-drying for powdered formulas. Ultrahigh-temperature (UHT)-treated formula has become more commonly used in recent years. The brief (2-3 s) treatment at 142 ЊC causes little protein denaturation but ensures sterility of the product (as routinely tested by the manufacturer). Compared with conventional retort sterilization (118 ЊC for 10-15 min), this mild heat treatment has less harmful effects on the digestibility of the protein. Our previous in vitro studies (8) as well as in vivo studies in suckling rat pups (9) showed that the protein digestibility of UHT-treated formula is higher than that of powdered and retort-sterilized liquid formulas. We were therefore interested in evaluating the effect of UHTtreated formula on plasma amino acids and BUN concentrations in infants and comparing a lower protein concentration in such a product with a powdered product with the same protein concentration that had been spray-dried (< 60 ЊC). In Sweden and Finland there are no liquid retort-sterilized milk formulas on the market.
The amount of protein in infant formula has been shown to affect the zinc status of infants; higher amounts of protein led to lower serum zinc concentrations (10) . It is likely that the low serum zinc concentrations are caused by high plasma histidine concentrations (10); a high protein intake results in high uptake of histidine, which has been shown to result in zinc deficiency in human adults through high urinary zinc losses (11) . Free amino acids, such as cysteine, have been shown to affect iron absorption, possibly by a chelation effect (12) . Iron absorption has also been shown to be affected by bovine milk proteins (13) . It is possible that heat treatment may influence the release of free amino acids as well as the inhibitory effect of the milk proteins. It therefore appeared prudent to evaluate iron and zinc status of the infants fed these products with different amounts of protein. In addition, because the 2 UHT-treated formulas of interest were manufactured in Finland, which is known as a country with a low selenium intake (14), we were interested in assessing the selenium status of these infants and comparing it with that of breastfed infants.
SUBJECTS AND METHODS

Subjects
Healthy, full-term infants were recruited from 3 well-baby clinics in Umeå, Sweden. The protocol for the study was approved by the Ethics Committee on Research Involving Human Subjects of the Medical Faculty, at Umeå University.
All infants were initially breast-fed and then allocated to breast-fed (BF) or formula-fed groups according to the mothers' choice. To be recruited to one of the formula groups the infant had to be completely weaned from the breast at 4 ± 2 wk of age. Anthropometric measurements were taken monthly and a venous blood sample (2-3 h postprandially, as observed by the research nurse when collecting the sample in each infant's home) at the start of the study and at 6 mo of age when the study was discontinued. Length was measured to the nearest 0.5 cm with use of a Harpenden measuring device. Weight was measured to the nearest 1 g by using an electronic balance. All recruited infants completed the study. Hematologic indexes were analyzed immediately. Plasma was separated within a few hours and stored frozen at Ϫ20 ЊC until analyzed. Red blood cells were washed with saline and frozen at Ϫ20 ЊC until analyzed.
Diets
Infants were either exclusively breast-fed or fed milk-based (whey predominant, 60:40) powdered infant formula from 6 ± 2 wk of age until the end of the study at 6 mo of age. Three reference groups, 1 that was breast-fed (BF group) and 2 groups fed powdered formula with 2 different amounts of iron (PF groups) were part of a previous study performed just before this study and in the same population (15) . The powdered formula was diluted with tap water according to the manufacturer's instructions. No iron drops or solid foods were allowed. However, limited quantities of fruit purées (without iron) were allowed at 4-6 mo of age. These were provided by the investigators and chosen to minimize interference with trace element status. Infants were assigned to the 2 UHT-treated formula groups in a randomized, double-blind design. Each group had ≥ 10 infants. The 2 UHT-treated formulas, with 13 (UHT-13) and 15 (UHT-15) g protein/L, respectively, were manufactured by Valio Ltd (Helsinki), whey-adjusted with electrodialyzed whey, and provided in 200-mL, gas-impermeable packages. The composition of the formulas is given in Table 1 . The powdered formula contained 13 g protein/L, whey-adjusted by ultrafiltered whey, and was manufactured by Semper AB, Stockholm. Both of the UHTtreated formulas contained 7 mg Fe as FeSO 4 per liter; the powdered formula was manufactured with 2 different amounts of iron and contained 4 (PF-4) or 7 (PF-7) mg Fe as FeSO 4 per liter. The detailed hematologic and trace element data for the latter 2 groups were published earlier (15) . The amino acid compositions of the formulas are given in Table 2 .
Blood urea nitrogen and plasma amino acids
Blood urea nitrogen (BUN) was determined by using a commercial kit with urease (Sigma, St Louis). Proteins were separated from plasma by sulfosalicylic acid precipitation (6%), and free amino acids, including tryptophan, were analyzed in the supernate with a Beckman 6000 amino acid analyzer (Beckman Instruments Inc, Palo Alto, CA).
Hematologic and biochemical indexes
Hemoglobin was analyzed by the cyanomethemoglobin method, mean corpuscular volume by Coulter counter (model STKR; Coulter Electronics, Inc, Miami), serum iron and transferrin saturation by commercial kits (Boehringer Mannheim, Indianapolis), serum ferritin by radioimmunoassay (Diagnostic Products Corporation, San Diego), and serum transferrin receptor by enzyme-linked immunosorbent assay (R&D Systems, Minneapolis). Serum zinc and copper concentrations were determined by atomic absorption spectrophotometry (16) . Serum glutathione peroxidase activity was assayed by the method of Paglia and Valentine (17) .
Statistical analyses
Statistical analyses were performed by using analysis of variance (ANOVA) with SAS (release 6.12; SAS Institute, Inc, Cary, NC). Data were tested for residuals and no skewness was found. When the ANOVA indicated significant group differences (P < 0.05), multiple comparisons were performed by using Tukey's method to identify which groups differed (P < 0.05). Values in tables and figures are given as means ± SDs. With the number of subjects per group and the number of groups used in this study we were able to detect weight differences > 7.4 g/d and height differences > 0.20 mm/d with 80% power.
RESULTS
There were no significant differences in weight or length at birth or at 6 wk (data not shown) or 6 mo of age among the groups (Table 3) , nor were there any significant differences in weight or length gain during the study period. There were no significant differences in any of the hematologic or biochemical variables at the start of the study (6 ± 2 wk). At 6 mo of age, mean BUN concentrations in infants in the UHT-15 and PF groups (13 g protein/L) were significantly higher than those in breast-fed infants (Figure 1 ). Among the formula-fed groups, infants fed UHT-13 had the lowest mean BUN concentration, which was significantly lower than that in the UHT-15 and PF groups, but not significantly different from that in the BF group.
Concentrations of the branched-chain amino acids valine and isoleucine were significantly higher in infants fed UHT-15 than in BF infants (Figure 2) . Infants fed UHT-13 had protein concentrations closest to those of BF infants. Tryptophan concentrations were significantly higher in both of the UHT-treated formula groups than in the BF and PF groups. Plasma tyrosine concentrations were significantly higher in infants fed UHT-15 than in infants fed UHT-13. Infants in the UHT-15 and PF groups had plasma phenylalanine concentrations significantly higher than those in BF infants. Methionine concentrations were significantly higher in both groups fed UHT-treated formula than in BF infants. Histidine concentrations were significantly lower in infants fed either of the UHT-treated formulas than in infants in the PF group. There were no significant differences in leucine or arginine concentrations among groups.
Plasma threonine was significantly higher in infants in the PF group than in BF infants, whereas infants fed UHT-treated formula had intermediate concentrations (Figure 2 ). Glycine and aspartic acid or asparagine concentrations were higher in infants fed UHT-13 than in BF infants, whereas glutamic acid or glutamine concentrations were higher in infants in either of the UHTtreated formula groups than in the PF group (Figure 3 ). There were no significant differences in concentrations of serine, glycine, proline, lysine, taurine, or alanine.
There were no significant differences in hemoglobin concentrations between the groups at 6 mo of age ( Table 4) . Serum ferritin concentrations varied considerably within groups, but the mean value was significantly higher for infants in the UHT-13 than in the UHT-15 group. There was no infant in any group with a serum ferritin value < 12 g/L, which would indicate depleted iron stores. Serum transferrin receptor concentrations in the BF group were significantly higher than those in the UHT-13 group; the UHT-15 group had concentrations significantly higher than those in the PF-7 group. Serum zinc and copper concentrations were not significantly different between groups (Table 4 ). Serum glutathione peroxidase activity was significantly higher in BF infants than in all formula-fed groups.
DISCUSSION
The capacity of an infant formula to meet the protein requirement of infants can be assessed in several ways (18) . A basic criterion, of course, is that the infants consuming the formula grow normally. For formula-fed infants, this is usually interpreted as having a growth pattern commensurate with the National Center for Health Statistics standards (NCHS; 19). It has been argued that these standards were established largely on the Fels data, which were obtained for infants fed formulas with higher energy and protein contents than those currently used. One consequence of this reasoning is that attempts are being made to establish separate growth standards for breast-fed infants (20) . A revision of the NCHS standards for formula-fed infants has not yet been made, although Guo et al (21) published reference data on weight and length of infants ≤ 2 y of age. In our study, all 3 groups of formula-fed infants showed growth patterns that were not significantly different from those of breast-fed infants and in agreement (22) suggested that a safe protein-energy ratio for milk formula is 1.44 g/100 kcal (418 kJ) from 56 to 83 d of age and 1.25 g/100 kcal from 84 to 111 d of age. The lowest protein concentration used in our study was 4.64 mg/kJ (1.94 g/100 kcal), which is considerably above these minimum amounts. Another way to assess the adequacy of a formula to supply amino acids to growing infants is to analyze plasma amino acid concentrations in a fasting state, usually 2-4 h postfeeding (23) . It is generally assumed that plasma amino acid concentrations of formula-fed infants should be similar to those of breast-fed infants and that significantly lower or higher amounts may be considered as possibly inadequate or excessive. In our study, infants fed the UHT-13 formula had plasma amino acid concentrations that were similar to those of BF infants, whereas several amino acids in infants fed the UHT-15 formula were higher than in BF infants. This was particularly notable for the branchedchain amino acids (valine and isoleucine), but also for tyrosine and phenylalanine. It has been suggested that high concentrations of branched-chain amino acids may be responsible for the elevated concentrations of C-peptide found in the urine of infants fed formula with high protein concentrations (24) . This, in turn, may be indicative of elevated serum insulin concentrations, the long-term effects of which are not yet known. In any case, it appears that a protein concentration of 15 g/L is unnecessarily high, at least for infants > 6 wk of age. In one of our previous studies we showed that formula with a protein concentration of 15 g/L resulted in significantly higher BUN and several plasma amino acid concentrations in infants than did a formula with 13 g/L or breast milk at 2, 4, 8, and 12 wk of age (6) . This finding agrees with those of several other studies (4-7).
A concern with reducing the protein concentration of wheypredominant formula has been that the amino acid tryptophan may become limiting. Some studies have shown significantly lower plasma tryptophan concentrations in infants fed formulas with 13 g protein/L than in breast-fed infants (4, 5, 7) . It should be cautioned, however, that several of these formulas had a crude protein concentration of 13 g/L, but the true protein concentration was (or was likely to have been) considerably lower because of a high nonprotein nitrogen content in the whey protein sources used in the formulas (25) . The UHT-treated formulas used in this study had a low nonprotein nitrogen content (10%) and, consequently, the true protein concentration was closer to the crude protein concentration of 13 g/L. This amount of protein resulted in plasma tryptophan concentrations that were not lower than those of the BF infants. In fact, plasma concentrations of all amino acids in the infants fed the formula with 13 g/L were similar to or higher than those of the BF infants. We therefore do not believe there is any reason to fortify this type of formula with tryptophan, as was done in some studies (7, 26, 27) . a Significantly higher than the BF group, b significantly different from the PF group, and c significantly higher than the BF and PF groups, P < 0.05.
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Some concern has also been raised that elevated plasma threonine concentrations in infants fed whey-predominant formula may reach excessive concentrations that may affect transport of other amino acids through the blood-brain barrier (28) . In our study, the threonine concentrations of the infants fed the UHT-13 formula were not significantly different from those of BF infants whereas infants fed UHT-15 had higher concentrations of threonine. It does not seem likely that this plasma threonine concentration would have any negative effects on these infants; however, the lower amount of protein would make this even less likely.
BUN concentrations have been used as a crude indicator of protein excess (29) . When infants receive protein intakes that are higher than their metabolic needs, serum urea concentrations rise. It has been shown in several studies that infants fed formulas with high concentrations of protein have BUN concentrations that are considerably higher than those of breast-fed infants (10, 30, 31) . In our study, infants in the PF and UHT-15 groups had significantly higher BUN concentrations than BF infants. Infants fed UHT-13 formula had values closest to those of the BF infants. Note, however, that the differences in BUN were small and there were no significant differences between the 3 formulafed groups. In fact, all formula-fed infants in our study had BUN values considerably lower than those reported in infants fed formula with high amounts of protein. Infants in the PF group had somewhat higher concentrations of BUN and some amino acids than those in the UHT-13 group, even if the 2 formulas had similar amounts of protein. It is possible that the different heat treatments that these 2 formulas received affected protein digestibility and amino acid absorption differently; alternatively, the 2 different whey protein sources used may explain the difference. The powdered formula was made of ultrafiltered whey, which has considerably higher nonprotein nitrogen and urea concentrations than the electrodialyzed whey, which was used in the UHTtreated formulas. This higher urea concentration may explain the higher BUN concentrations of infants in the PF group. It is not likely that the formula-fed groups differed in relevant characteristics (although this was not a strictly randomized design) because the characteristics of the 3 groups were not different at the start of the study.
Overall, the major difference in indexes of protein metabolism was between the UHT-15 and BF groups, whereas the differences between the UHT-13 and PF groups and the BF group must be considered minor. There were no significant differences in hemoglobin concentrations among groups. There were, however, several infants in each group that had hemoglobin values < 107 g/L, a suggested cutoff for anemia in this age group (32) , but none of them had low serum ferritin concentrations or were iron deficient as judged by multiple criteria. Except for infection, anemia due to causes other than iron deficiency is highly unlikely in this population. Limited data from infants in the third National Health and Examination Survey suggest that hemoglobin values < 105-107 g/L may be physiologic at < 12 mo of age (P Dallman, personal communication, 1996) and not necessarily indicative of iron deficiency. A recent study from the United Kingdom also found a relatively large percentage (23%) of 8-mo-old infants to be considered anemic (33) . On the basis of data from a large number of infants (n = 1175), these authors suggested that a more appropriate cutoff at this age would be 97 g/L. It is likely that new cutoff values for hemoglobin will be established for infants < 1 y of age. Serum ferritin concentrations were satisfactory in all groups and no infant had a value < 12 g/L, which would indicate depleted iron stores.
We also used serum transferrin receptor concentration as an index of iron status. It has been shown that circulating concentrations of transferrin receptor are correlated with cellular iron needs in adults and that concentrations are elevated in situations of iron depletion (34, 35) . This index was used previously to diagnose iron deficiency in adult humans (36) and has several advantages, such as not being affected by infection. In our study, breast-fed infants had the highest concentration of serum transferrin receptor at 6 mo of age. It is known that exclusively breastfed infants usually have satisfactory iron status at 6 mo of age (37, 38) but that they are at risk of iron deficiency at 9 mo of age (37). Thus, it is possible that the elevated concentrations of serum transferrin receptor are an early indication of increased cellular needs for iron at this age, although there are still no reference values for infants. The lowest concentrations of serum transferrin receptor were found in the group with the highest iron fortification (7 mg/L) and in infants fed the UHT-treated formula with 13 g protein/L and 7 mg Fe/L. This indicates that iron was well utilized from the UHT-treated formula with the lower amount of protein. Hurrell et al (13) showed that milk proteins can have a negative effect on iron absorption in adults and it is possible that phosphopeptides or other components are responsible for the inhibitory effect.
There were no significant differences in serum zinc or copper concentrations among groups. In an earlier study, we found lower serum zinc concentrations in infants fed follow-up formula with a high protein concentration (10) . We speculated that low zinc status was induced by increased urinary losses of zinc caused by high concentrations of serum histidine, a known chelator of zinc. In the present study, however, protein concentrations were much lower than in the previous study and we did not find any increases in serum histidine concentrations. In our study, all groups had similar serum copper concentrations. We found differences in the activity of serum glutathione peroxidase between the BF and the formulafed groups, most likely reflecting their different selenium intakes. It is known that dietary intake of selenium is well correlated with serum glutathione peroxidase activity (39) . The selenium concentration of breast milk from Swedish women is Ϸ15 g/L (40), which is higher than that of unfortified powdered formula (5 g/L). This is reflected by a significantly higher serum glutathione peroxidase activity (15) . When the formula was fortified with selenium to a total amount similar to that of breast milk, glutathione peroxidase activity also became similar to that of breast-fed infants. In this study, the UHT-13 and UHT-15 formulas were not fortified with selenium and contained 7 and 8 g/L, respectively. The activity of glutathione peroxidase in these 2 groups was similar to that of infants fed the unfortified powdered formula.
In conclusion, it appears that feeding UHT-treated formula or powdered formula with a protein concentration of 13 g/L results in satisfactory growth, hematology, trace element status, and plasma amino acid patterns as compared with breast-fed infants. Concentrations of several amino acids and BUN in infants fed this amount of protein are closer to those of breast-fed infants than are corresponding values from infants fed formula with 15 g protein/L. In addition, low serum transferrin receptor concentrations in the group fed the UHT-treated formula with 13 g protein/L suggest that iron was well utilized from this formula.
TABLE 4
Hematologic and biochemical indexes of study groups at 6 mo of age 
